GH Research Plc (GHRS)

28.24 +0.32 (+1.13%) USD  |  NASDAQ  |  Sep 04, 16:00
28.24 0.00 (0.00%) After-Hours: 16:45
More

GH Research Cash from Investing (Quarterly) : 6.295M for June 30, 2026

Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for GHRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 6.295M
March 31, 2026 8.637M
December 31, 2025 8.566M
September 30, 2025 10.46M
June 30, 2025 16.75M
March 31, 2025 11.84M
December 31, 2024 19.95M
September 30, 2024 15.86M
June 30, 2024 19.62M
March 31, 2024 8.788M
December 31, 2023 0.6247M
Date Value
September 30, 2023 0.0163M
June 30, 2023 -0.434M
March 31, 2023 -54.02M
December 31, 2022 -82.15M
September 30, 2022
June 30, 2022
March 31, 2022 -0.01M
December 31, 2021 -0.0169M
September 30, 2021 -0.0486M
June 30, 2021 -0.014M
March 31, 2021 -0.021M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Atai Beckley, Inc. 158.15M
Avadel Pharmaceuticals Plc -8.788M
Jazz Pharmaceuticals Plc 354.90M
Eli Lilly & Co. -15.40B
Perrigo Co. Plc 349.40M

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly) -14.94M
Cash from Financing (Quarterly) 111.51M
Free Cash Flow -52.46M
Free Cash Flow Per Share (Quarterly) -0.2248
Free Cash Flow to Equity (Quarterly) -14.88M
Free Cash Flow to Firm (Quarterly) -14.87M
Free Cash Flow Yield -2.94%